We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

148 hedge funds and large institutions have $839M invested in Cardiovascular Systems, Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 49

3% more call options, than puts

Call options by funds: $486K | Put options by funds: $473K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 159148 (-11)

26% less capital invested

Capital invested by funds: $1.13B → $839M (-$288M)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

Holders
148
Holders Change
-11
Holders Change %
-6.92%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
59
Reduced
49
Closed
28
Calls
$486K
Puts
$473K
Net Calls
+$13K
Net Calls Change
+$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
State of New Jersey Common Pension Fund D
101
State of New Jersey Common Pension Fund D
New Jersey
$427K
MIM
102
MetLife Investment Management
New Jersey
$426K
Susquehanna International Group
103
Susquehanna International Group
Pennsylvania
$421K +$469K +14,775 New
PIM
104
Partner Investment Management
California
$415K +$108K +3,407 +31%
VOYA Investment Management
105
VOYA Investment Management
Georgia
$403K +$26K +818 +6%
CSS
106
Cubist Systematic Strategies
Connecticut
$402K +$448K +14,105 New
HI
107
HBK Investments
Texas
$394K -$37.6K -1,184 -8%
US Bancorp
108
US Bancorp
Minnesota
$389K +$38.9K +1,226 +10%
FFA
109
First Foundation Advisors
California
$370K
MC
110
Menta Capital
California
$357K -$172K -5,416 -30%
AIM
111
Assured Investment Management
New York
$355K -$453K -14,276 -53%
MLICM
112
Metropolitan Life Insurance Company (MetLife)
New York
$325K
FMT
113
First Mercantile Trust
Tennessee
$298K -$36.1K -1,135 -10%
WMSA
114
Weiss Multi-Strategy Advisers
New York
$285K -$1.08K -34 -0.3%
NSEDCP
115
NJ State Employees Deferred Compensation Plan
New Jersey
$285K +$31.8K +1,000 +11%
DT
116
Diversified Trust
Tennessee
$283K +$44.5K +1,400 +16%
SWP
117
Stratos Wealth Partners
Ohio
$274K
Commonwealth Equity Services
118
Commonwealth Equity Services
Massachusetts
$259K
UBS AM
119
UBS AM
Illinois
$252K -$190K -5,968 -40%
JP Morgan Chase
120
JP Morgan Chase
New York
$247K +$36K +1,133 +15%
Citigroup
121
Citigroup
New York
$245K +$164K +5,148 +149%
QT
122
Quantbot Technologies
New York
$245K +$243K +7,661 +816%
CI
123
Cigna Investments
Connecticut
$240K
PVI
124
Pura Vida Investments
New York
$227K +$253K +7,952 New
XK
125
Xact Kapitalforvaltning
Sweden
$219K

CSII Hedge Fund Activity: Q4 2018 in Review

148 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2018, worth a combined $839M — down 26% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CSII and 18 opened new positions — a net loss of 10 holders — while 49 trimmed existing stakes and 59 added.

The largest buyer was PFM Health Sciences, adding an estimated $18.5M. The largest seller was Deutsche Bank, cutting an estimated $17.2M.

  • 148 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2018, down from 159 in Q3 2018.
  • Funds reported $839M of Cardiovascular Systems, Inc. stock for Q4 2018, down 26% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q4 2018 and 28 closed out, a net change of -10 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2018 was PFM Health Sciences, an estimated $18.5M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2018 was Deutsche Bank, an estimated $17.2M sold.

Based on aggregated 13F filings for Q4 2018.